Expression of Sulf1Scer\UAS.cBa under the control of Scer\GAL4en-e16E does not result in a wing vein loss phenotype.
Expression of Sulf1Scer\UAS.cBa under the control of Scer\GAL4vn-GAL4 results in a loss of anterior crossvein phenotype and a reduction in wing size.
Scer\GAL4en-e16E/Sulf1UAS.cBa is a suppressor | partially of lethal | pupal stage phenotype of Scer\GAL4en-e16E, vnUAS.cSa
Scer\GAL4Act5C.PU/Sulf1UAS.cBa is a suppressor of visible phenotype of EgfrE1
Scer\GAL4en-e16E, Sulf1UAS.cBa, vnUAS.cSa has visible phenotype
Scer\GAL4Act5C.PU/Sulf1UAS.cBa is a suppressor of wing vein | ectopic phenotype of EgfrE1
Scer\GAL4en-e16E, Sulf1UAS.cBa, vnUAS.cSa has wing phenotype
Scer\GAL4en-e16E, Sulf1UAS.cBa, vnUAS.cSa has wing vein | ectopic phenotype
Expression of Sulf1Scer\UAS.cBa under the control of Scer\GAL4Act5C.PU suppresses the extra wing vein phenotype of EgfrE1 flies.
Co-expression of Sulf1Scer\UAS.cBa suppresses the lethality caused by expression of vnScer\UAS.cSa under the control of Scer\GAL4en-e16E such that some adults survive to adulthood. The survivors have extra wing veins and blisters in the posterior region of the wing.